Consider lowering the dose of these agents when coadministered with FARXIGA Pooled safety data across 12 placebo-controlled clinical studies of glycemic control in adults with T2D 1 Adverse reactions reported in 2% of adults taking FARXIGA 10 mg (n=1193) vs placebo (n=1393) included female genital mycotic infections (6.9% vs 1.5%), nasopharyngitis (6.3% vs 6.2%), UTIs (4.3% vs 3.7%), back pain (4.2% vs 3.2%), increased urination (3.8% vs 1.7%), male genital mycotic infections (2.7% vs 0.3%), nausea (2.5% vs 2.4%), dyslipidemia (2.5% vs 1.5%), influenza (2.3% vs 2.3%), and discomfort with urination (2.1% vs 0.7%)
Aligns with the diurnal insulin sensitivity peak
This common question arises among patients prescribed Ozempic or Wegovy for type 2 diabetes or weight management
Eric Xu Qilu Regor Therapeutics Inc., 1206 Zhangjiang Road, Building C, Pu Dong New District, Shanghai, 201210, China Wei Huang, Wei Guo, Xianqiang Sun, Wenge Zhong & Daopeng Yuan Regor Pharmaceuticals Inc., 50 Soldiers Field Pl, Boston, MA, 02135, USA Feng Liu Authors Honglei Ma Wei Huang Xiaoxi Wang Lihua Zhao Yi Jiang Feng Liu Wei Guo Xianqiang Sun Wenge Zhong Daopeng Yuan H
If youre consistently left with leftover medication, lets talk
Makhijani K, Kumbhare LB, Nayak M, Kunwar A, Singh BG